First Interim Results of the PERFORM Study for Evaluating First-line Endocrine-based Palbociclib Therapy for Patients with HR+/ HER2-advanced Breast Cancer in the Real World

T. Fietz, J. Wilke, M. Deryal, T. Gabrysiak, B. Schoettker, L. Jacobasch, V Petersen, M. Weigel, D. Wrobel, E. Glastetter, L. Berger, M. Frank, S. M. Woerner,A. Adams, A. Woeckel, M. P. Lux

ONCOLOGY RESEARCH AND TREATMENT（2022）

引用 0|浏览0